The fate and behaviour of antimonial drugs labelled with 124 Sb in bilharzial subjects.
D000965:Antimony / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D001201:Ascites / Q000378:metabolism; D004639:Emetics / Q000627:therapeutic use; D006529:Hepatomegaly / Q000378:metabolism; D006801:Humans; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D010879:Piperazines / Q000378:metabolism / Q000627:therapeutic use / Q000652:urine; D011868:Radioisotopes; D012552:Schistosomiasis / Q000188:drug therapy* / Q000378:metabolism; D012556:Schistosomicides / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D013163:Splenomegaly / Q000378:metabolism; D013644:Tartrates / Q000378:metabolism / Q000627:therapeutic use / Q000652:urine; D013961:Thyroid Gland / Q000378:metabolism; D014552:Urinary Tract Infections / Q000378:metabolism
D004639:Emetics; D010879:Piperazines; D011868:Radioisotopes; D012556:Schistosomicides; D013644:Tartrates; D000965:Antimony